Nervgen Pharma Corp (TSE:NGEN) has released an update.
NervGen Pharma Corp., a biotech company focused on treating nervous system damage, has partnered with Russo Partners LLC for public relations services. The New York-based firm, with expertise in healthcare communication, will help NervGen elevate its media presence for at least three months, with the possibility of extension. This strategic move, pending regulatory approval, aims to bolster NervGen’s visibility as it advances clinical trials for its lead drug candidate.
For further insights into TSE:NGEN stock, check out TipRanks’ Stock Analysis page.
